| 1 |
Clinical application of mTORi based immunosuppression for renal transplantation in India |
|
| | Chacko, B. | | | Clinical Transplantation. 2012; 26(1): 1-15 | | | [Pubmed] [Google Scholar] | | | 2 |
Drugs that act on the immune system. immunosuppressive and immunostimulatory drugs |
|
| | Aronson, J.K. | | | Side Effects of Drugs Annual. 2011; 33(1): 815-839 | | | [Pubmed] [Google Scholar] | | | 3 |
Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: Etiology, pathogenesis and treatment |
|
| | Kahan, B. | | | Expert Opinion on Drug Safety. 2011; 10(5): 727-749 | | | [Pubmed] [Google Scholar] | | | 4 |
Impact of everolimus: Update on immunosuppressive therapy strategies and patient outcomes after renal transplantation |
|
| | Tedesco-Silva Jr., H. and Felipe, C.R. and Freitas, T.V.S. and Cristeli, M.P. and Rodrigues, C.A. and Pestana, J.O.M. | | | Transplant Research and Risk Management. 2011; 3: 9-29 | | | [Pubmed] [Google Scholar] | | | 5 |
Common occurrence of everolimus-associated aphthous stomatitis in Japanese heart transplant recipients |
|
| | Sasaoka, T. and Kato, T.S. and Oda, N. and Wada, K. and Komamura, K. and Asakura, M. and Hashimura, K. and Ishibashi-Ueda, H. and Nakatani, T. and Isobe, M. and Kitakaze, M. | | | Transplantation Proceedings. 2010; 42(9): 3700-3703 | | | [Pubmed] [Google Scholar] | | | 6 |
Side effects of proliferation signal inhibitors and their management [Effets secondaires des inhibiteurs du signal de prolifération et leur gestion] |
|
| | Epailly, E. and Lorho, R. | | | Gastroenterologie Clinique et Biologique. 2009; 33(SUPPL. 4): S268-S274 | | | [Pubmed] [Google Scholar] | |
|
